Enclomiphene
Also known as: Androxal · trans-Clomiphene · Enclomiphene Citrate
A selective estrogen receptor modulator (SERM) that stimulates endogenous testosterone production while preserving fertility, used as an alternative to TRT.
Overview
Enclomiphene is the trans-isomer of clomiphene citrate, isolated from the racemic mixture that also contains zuclomiphene (the cis-isomer). While traditional clomiphene (Clomid) contains both isomers, enclomiphene is preferred because zuclomiphene has a much longer half-life and accumulates, potentially causing estrogenic side effects. Enclomiphene acts as a selective estrogen receptor modulator (SERM), blocking estrogen receptors in the hypothalamus and pituitary. By blocking estrogen's negative feedback at the hypothalamus, enclomiphene increases GnRH pulse frequency, which stimulates LH and FSH release from the pituitary. This results in increased endogenous testosterone production while maintaining — or even improving — spermatogenesis.
This makes enclomiphene an attractive option for men who want to optimize testosterone levels while preserving fertility, or as an alternative to TRT for men with secondary hypogonadism. It can also be used alongside TRT at low doses to maintain gonadotropin signaling.
Mechanism of Action
Selectively antagonizes estrogen receptors (ER) in the hypothalamus and anterior pituitary, blocking estradiol's negative feedback on GnRH neurons. This increases GnRH pulsatility, stimulating gonadotroph cells to release more LH and FSH. LH stimulates Leydig cells to produce testosterone; FSH stimulates Sertoli cells to support spermatogenesis.
Key Benefits
Potential Side Effects
Common Stacks
This peptide is commonly combined with the following compounds for synergistic effects:
Known Interactions
The following interactions have been documented for Enclomiphene. Always consult a healthcare professional before combining compounds.
Use Caution (1)
Enclomiphene stimulates natural testosterone production via SERM action. Using with exogenous testosterone is counterproductive — the exogenous T suppresses the HPG axis that enclomiphene is trying to stimulate.
Synergistic (2)
Both support endogenous testosterone production through different mechanisms. Enclomiphene (SERM) stimulates LH/FSH release while HCG directly stimulates Leydig cells.
Kisspeptin stimulates GnRH release upstream while enclomiphene blocks estrogen's negative feedback. Both promote endogenous testosterone through complementary HPG axis mechanisms.
Scientific References
Quick Reference
Typical Dose
12.5-25 mg/day
Frequency
Once daily
Route
Oral capsule/tablet
Half-Life
~10 hours
Cycle Length
Ongoing or cyclical; monitor testosterone, LH, FSH, estradiol
FDA Status
Not FDA approved (was in Phase 3 trials as Androxal); available through compounding pharmacies
Need to calculate dosing?
Use our reconstitution calculator to determine exact syringe measurements.
Open CalculatorThis information is for educational purposes only. Consult a qualified healthcare professional before using any peptide. Dosing information reflects commonly reported protocols and may not be appropriate for everyone.
Related Peptides in Pharmaceuticals
Tadalafil
A long-acting PDE5 inhibitor originally developed for erectile dysfunction, now widely used for cardiovascular health, blood flow optimization, prostate health, and exercise performance.
Read moreOxandrolone
A mild oral anabolic steroid with a high anabolic-to-androgenic ratio, used medically for muscle wasting and increasingly studied for its effects on body composition and recovery.
Read moreAnastrozole
A potent aromatase inhibitor that reduces estrogen conversion from testosterone, used to manage estradiol levels during TRT and hormone optimization.
Read more